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Introduction
Critically ill patients have a high risk of deep venous
thrombosis and pulmonary embolism, which comprise
venous thromboembolic disease (VTED). Prevention dur-
ing critical illness is a widely used quality metric and safety
initiative for these patients.
Objective
To evaluate the effectiveness of a bundle of VTED prophy-
lactic measures upon completion of a project aim to
improve patient safety in this entity.
Methods
We designed a three phases prospective study of patients
admitted to a general ICU of a tertiary university hospital.
During first 4 months, weekly collection days are estab-
lished, gathering demographic variables, reason for admis-
sion, severity scores, risk factors for hemorrhage and
thrombosis as well as VTED prophylactic measures pre-
scribed. Data were analyzed using a Failure Mode and
Effects Analysis (FMEA) from which a set of measures
were developed and the implementation of a VTED pro-
phylaxis protocol. After that, we collected data during
5 months to compare the effectiveness of the protocol.
Finally, a checklist was introduced to facilitated the adher-
ence to these measures. The impact of this checklist was
evaluated for 2 more months. All results were analyzed
using the SPSS v22.0.0 statistical analysis software.
Results
In the first period we enrolled 59 patients, 42 of them
(71.2%) received prophylaxis for VTE (63.4% had
pharmacological prophylaxis and 34.1% mechanical)
and 2.4% received dual prophylaxis. Seventeen patients
(28.8%) received no prophylaxis, 2 of them had contra-
indication to any type of VTED thromboprophylaxis.
Post-FMEA, we enrolled 97 patients, 89 of them
(91.7%) received prophylaxis for VTED: 55% received
pharmacological prophylaxis and 45% mechanical
devices. Dual prophylaxis was received by 6.25% of
patients. From those who received mechanical devices,
67.9% received compression stockings. Seven patients
(8.2%) presented high risk of bleeding and did not receive
prophylaxis. One patient had contraindication for both
types of measures.
Post checklist we included 40 patients, 39 of them
(97.5%) of them received prophylactic measures: 73.5%
received pharmacological prophylaxis and 32.5% mechani-
cal devices. Dual prophylaxis were applied in 25% of
patients. Only 1 patient (2.5%) had double contraindica-
tion for VTED measures.
Conclusions
The number of patients with high risk of thrombosis as
well as those who receive dual prophylaxis has increased
after the implemetation of a VTED prophylaxis protocol.
The development of a daily checklist could be a useful
tool to monitor adherence to this protocol. All of these
measures are expected to improve patient safety.
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